• 1 of 4 of those with COPD symptoms in surveyed countries remain undiagnosed
• COPD poses a heavy burden burden in Asia, particularly in the Philippines: Among the Filipino respondents, 62% were unable to work, and 70% of those able to work full-time or part on average miss 14 days at work
• Majority of sufferers worry about COPD lung attacks affecting their quality of life
• Once daily tablet, roflumilast, a first-in-class treatment is launched to target the underlying cause of COPD and reduce risk of COPD lung attacks
